NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday
Portfolio Pulse from Avi Kapoor
Top Wall Street analysts have updated their outlooks on several major stocks. Notable changes include Citigroup raising NVIDIA's price target, Truist Securities increasing Rivian Automotive's target, and BTIG cutting Exact Sciences' target. Other significant updates involve FedEx, StoneCo, Amazon, ANI Pharmaceuticals, Repligen, United States Steel, and Accenture.
June 26, 2024 | 12:13 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
B of A Securities raised Amazon's price target from $210 to $220, maintaining a Buy rating. Amazon shares gained 0.4% to close at $186.34.
The increased price target and maintained Buy rating from B of A Securities are likely to positively influence investor sentiment, leading to a short-term boost in Amazon's stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
HC Wainwright & Co. raised ANI Pharmaceuticals' price target from $87 to $94, maintaining a Buy rating. ANI Pharmaceuticals shares gained 2.2% to close at $64.19.
The increased price target and maintained Buy rating from HC Wainwright & Co. suggest a positive outlook, likely leading to a short-term boost in ANI Pharmaceuticals' stock price.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Citigroup raised NVIDIA's price target from $126 to $150, maintaining a Buy rating. NVIDIA shares gained 6.8% to close at $126.09.
The significant price target increase and maintained Buy rating from Citigroup are likely to boost investor confidence, leading to a positive short-term impact on NVIDIA's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Deutsche Bank cut Repligen's price target from $180 to $155, upgrading the stock from Hold to Buy. Repligen shares fell 0.4% to close at $123.15.
The price target cut but upgrade to Buy from Deutsche Bank indicates a mixed but overall positive outlook, likely leading to a short-term boost in Repligen's stock price.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Truist Securities raised Rivian Automotive's price target from $10 to $13, maintaining a Hold rating. Rivian shares gained 8.6% to close at $11.96.
The increased price target from Truist Securities, despite a Hold rating, suggests a positive outlook, likely leading to a short-term boost in Rivian's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
BMO Capital raised United States Steel's price target from $43 to $45, upgrading the stock from Market Perform to Outperform. United States Steel shares fell 2.9% to close at $35.21.
The increased price target and upgrade to Outperform from BMO Capital suggest a positive outlook, likely leading to a short-term boost in United States Steel's stock price despite the recent decline.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEUTRAL IMPACT
Morgan Stanley boosted FedEx's price target from $210 to $215, maintaining an Equal-Weight rating. FedEx shares fell 0.1% to close at $256.38.
The slight increase in price target with an Equal-Weight rating suggests a neutral outlook, likely resulting in minimal short-term impact on FedEx's stock price.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEUTRAL IMPACT
Goldman Sachs cut StoneCo's price target from $21 to $15, maintaining a Buy rating. StoneCo shares gained 1.1% to close at $11.94.
The reduced price target from Goldman Sachs, despite a Buy rating, indicates mixed signals, likely resulting in a neutral short-term impact on StoneCo's stock price.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 60
NEGATIVE IMPACT
Morgan Stanley slashed Accenture's price target from $382 to $300, downgrading the stock from Overweight to Equal-Weight. Accenture shares slipped 0.01% to close at $307.17.
The significant price target cut and downgrade from Morgan Stanley indicate a negative outlook, likely leading to a short-term decline in Accenture's stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
BTIG cut Exact Sciences' price target from $80 to $70, maintaining a Buy rating. Exact Sciences shares fell 1.4% to close at $41.37.
The reduced price target from BTIG, despite a Buy rating, indicates potential concerns, likely leading to a short-term negative impact on Exact Sciences' stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80